SHIONOGI & CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,285 JPY | -0.25% |
|
-11.62% | -7.46% |
| Jun. 07 | Japan's Nikkei little changed ahead of key US data, central bank meetings | RE |
| Jun. 07 | Japan's Nikkei edges down ahead of key US data, central bank meetings | RE |
| Sales 2024 | 435B 2.77B | Sales 2025 * | 432B 2.75B | Capitalization | 1,786B 11.38B |
|---|---|---|---|---|---|
| Net income 2024 | 162B 1.03B | Net income 2025 * | 155B 989M | EV / Sales 2024 | 5.05 x |
| Net cash position 2024 * | 473B 3.02B | Net cash position 2025 * | 542B 3.46B | EV / Sales 2025 * | 2.88 x |
| P/E ratio 2024 |
13.9
x | P/E ratio 2025 * |
11.5
x | Employees | 4,959 |
| Yield 2024 |
2.06% | Yield 2025 * |
2.63% | Free-Float | 87.27% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -0.16% | ||
| 1 week | -11.62% | ||
| Current month | -10.64% | ||
| 1 month | -16.00% | ||
| 3 months | -20.02% | ||
| 6 months | -11.85% | ||
| Current year | -7.46% |
1 week
6 106.00
7 314.00
1 month
6 106.007 650.00
Current year
6 106.008 137.00
1 year
5 718.008 137.00
3 years
5 490.008 439.00
5 years
4 379.008 439.00
10 years
2 019.008 439.00
| Managers | Title | Age | Since |
|---|---|---|---|
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Yuji Hosogai
DFI | Director of Finance/CFO | - | - |
Yasuetsu Imune
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hiroshi Ozaki
BRD | Director/Board Member | 74 | 19-05-31 |
Isao Teshirogi
CEO | Chief Executive Officer | 64 | 82-03-31 |
Takuko Sawada
BRD | Director/Board Member | 69 | 77-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.69% | 14 M€ | +12.93% | ||
| 2.51% | 7 M€ | +11.44% | - | |
| 1.07% | 57 M€ | +20.14% | ||
| 1.05% | 10 M€ | +16.91% | - | |
| 1.04% | 240 M€ | +18.59% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-09 | 6,285 | -0.25% | 1 377 200 |
| 24-06-07 | 6,301 | -12.91% | 9,368,200 |
| 24-06-06 | 7,235 | +0.37% | 968,900 |
| 24-06-05 | 7,208 | 0.00% | 731,200 |
| 24-06-04 | 7,208 | +1.26% | 780,700 |
Delayed Quote Japan Exchange, June 09, 2024 at 10:15 pm EDT
More quotes
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-07-28
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
6,301
JPY
Average target price
7,967
JPY
Spread / Average Target
+26.44%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.46% | 11.41B | |
| +45.82% | 765B | |
| -6.16% | 354B | |
| +19.86% | 331B | |
| +9.32% | 299B | |
| +18.45% | 248B | |
| -0.78% | 219B | |
| +11.88% | 216B | |
| +5.90% | 164B | |
| -0.73% | 162B |
- Stock Market
- Equities
- 4507 Stock
